The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hospitalization for immune related toxicity and overall survival (OS) among patients with metastatic non-small cell lung cancer (NSCLC) treated with first-line pembrolizumab.
 
Adam Khorasanchi
No Relationships to Disclose
 
Songzhu Zhao
No Relationships to Disclose
 
Lai Wei
No Relationships to Disclose
 
Mingjia Li
No Relationships to Disclose
 
Kevin Ho
No Relationships to Disclose
 
Hamzah Abu-Sbeih
No Relationships to Disclose
 
John Howard Alexander
No Relationships to Disclose
 
Evelyn Goodyear
No Relationships to Disclose
 
Austin Secor
No Relationships to Disclose
 
Peter G. Shields
No Relationships to Disclose
 
Kai He
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Geneplus; Iovance Biotherapeutics; Lyell Immunopharma; Mirati Therapeutics; Perthera
Research Funding - Abbvie (Inst); Adaptimmune (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Iovance Biotherapeutics (Inst); Mirati Therapeutics (Inst); Oncoc4 (Inst)
 
Jacob Kaufman
Consulting or Advisory Role - AstraZeneca
 
Regan Michelle Memmott
Consulting or Advisory Role - Takeda
 
Asrar Alahmadi
No Relationships to Disclose
 
David Paul Carbone
Employment - James Cancer Center
Honoraria - AstraZeneca; Bristol-Myers Squibb-Ono Pharmaceutical
Consulting or Advisory Role - Abbvie; Arcus Biosciences; AstraZeneca; Bristol-Myers Squibb; Curio Science; EMD Serono; Genentech/Roche; GlaxoSmithKline; Intellisphere; InThought; Iovance Biotherapeutics; Janssen; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Lilly; Merck; Merck KGaA; Mirati Therapeutics; MSD Oncology; NCCN/AstraZeneca; Novartis; OncLive/MJH Life Sciences; Pfizer; PPD; Regeneron; Roche; Sanofi
 
Gregory Alan Otterson
Consulting or Advisory Role - Novocure; OncLive/MJH Life Sciences
Research Funding - Apollomics (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Revolution Medicines (Inst)
 
Alexa Simon Meara
Honoraria - Association of Women in Rheumatology (AWIR); Lupus foundation of America
Consulting or Advisory Role - Abbvie; Amgen; Sanofi
Speakers' Bureau - Abbvie; Amgen; Aurinia Pharmaceuticals
 
Carolyn J Presley
Consulting or Advisory Role - Jazz Pharmaceuticals; Jazz Pharmaceuticals; Onc Live; Regeneron
 
Dwight Hall Owen
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Onc.AI (Inst); Palobiofarma (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Genentech